Canada, Feb. 26 -- Canada based Emergent BioDefense Operations Lansing has secured contract from Public Health Agency of Canada (PHAC) for Tembexa (brincidofovir) Smallpox antiviral. The value of the contract is not disclosed.
Published by HT Digital Content Services with permission from Pivotal Sources....